Biogen, Eisai begin filing application data for Alzheimer’s drug lecanemab in Japan
Naeblys/iStock through Getty Pictures Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALY) started submission of utility information in Japan ...
Read moreNaeblys/iStock through Getty Pictures Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALY) started submission of utility information in Japan ...
Read moreTry the businesses making headlines earlier than the bell:Biogen (BIIB) – Biogen slid 6.5% within the ...
Read moreTextual content measurement Biogen, which owns almost half of a Samsung unit, shares surged Wednesday. A ...
Read more Copyright © 2021 198 China News.
All Rights Reserved.
Copyright © 2021 198 China News.
All Rights Reserved.